½ÃÀ庸°í¼­
»óǰÄÚµå
1321380

¿ä½Ç±Ý ÆÐµå ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : Á¦Ç° À¯Çüº°, ȯÀÚº°, ÃÖÁ¾ ¿ëµµº°, À¯Åë ä³Îº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2023-2030³â)

Incontinence Pads Market Size, Share & Trends Analysis Report By Product Type, By Patient, By End-use, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 130 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¿ä½Ç±Ý ÆÐµå ½ÃÀå ¼ºÀå ¹× µ¿Çâ

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¿ä½Ç±Ý ÆÐµå ¼¼°è ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 106¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç 2023³âºÎÅÍ 2030³â±îÁö 5.73%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÅÀå ÇÕº´Áõ ¹× ½ÅÀå Àå¾ÖÀÇ Áõ°¡, ÀÏȸ¿ë ¿ä½Ç±Ý ÆÐµå Á¦Á¶¿¡ »ç¿ëµÇ´Â Àç·áÀÇ ±â¼ú ¹ßÀü, °³ÀÎ °ü¸® ¹× À§»ý¿¡ ´ëÇÑ ÀÏ¹Ý ´ëÁßÀÇ ÀÎ½Ä Áõ°¡ µîÀÌ ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù.

¿¹¸¦ µé¾î, ¹Ì±¹ ºñ´¢±â°ú ÇÐȸÀÇ º¸°í¿¡ µû¸£¸é ¹Ì±¹ ³²¼º ¹× ¿©¼ºÀÇ ÃÖ´ë 25%°¡ ¿ä½Ç±ÝÀ» ¾Î°í ÀÖÀ¸¸ç, ¾à 3,300¸¸ ¸íÀÌ Àý¹Ú°¨, ºó´¢, Àý¹Ú¼º ¿ä½Ç±Ý°ú °°Àº Áõ»óÀ» ³ªÅ¸³»´Â ¹æ±¤ °úȰ¼ºÀ» °æÇèÇϰí ÀÖ½À´Ï´Ù. ±× °á°ú, ¿ä½Ç±Ý ÆÐµå´Â ÀÌ·¯ÇÑ Àý¹Ú°¨°ú ºó´¢¸¦ Á¶ÀýÇϱâ À§ÇØ ÀÇ»çµéÀÌ »ç¶÷µé¿¡°Ô Á¦¾ÈÇϰí ÀÖ½À´Ï´Ù. µû¶ó¼­ ¿¹Ãø ±â°£ µ¿¾È ¿ä½Ç±Ý ÆÐµå¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¶ÇÇÑ, ¸¹Àº ½ÅÀå ÁúȯÀÇ Áõ°¡°¡ ½ÃÀå ¼ºÀå¿¡ µµ¿òÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, ¿µ±¹ÀÇ Kidney Care 2021 µ¥ÀÌÅÍ¿¡ µû¸£¸é 68,000¸í ÀÌ»óÀÌ ½ÅºÎÀü Ä¡·á¸¦ ¹Þ°í ÀÖÀ¸¸ç, 350¸¸ ¸í ÀÌ»óÀÌ ¸¸¼º ½ÅÀå ÁúȯÀ» ¾Î°í ÀÖ½À´Ï´Ù. ÀÌ Á¶»ç´Â ¶ÇÇÑ ¿µ±¹¿¡¼­ ¸ÅÀÏ ¾à 20¸íÀÌ ½ÅºÎÀüÁõÀ» ¾Î°í ÀÖ´Ù°í ÁöÀûÇß½À´Ï´Ù.

¶ÇÇÑ 2022³â 10¿ù ABC UKÀÇ º¸°í¼­¿¡ µû¸£¸é ¿µ±¹¿¡¼­´Â ¸Å³â ¾à 20,500°ÇÀÇ ¹æ±¤¾ÏÀÌ »õ·Î Áø´ÜµÇ¾î Àüü ½Å±Ô ¾Ï ȯÀÚÀÇ 4.5%¸¦ Â÷ÁöÇÕ´Ï´Ù. ÀÌ¿¡ µû¶ó Àü ¼¼°èÀûÀ¸·Î ¹æ±¤¾ÏÀÇ À¯º´·ü Áõ°¡´Â ¹æ±¤¾Ï ¿ä½Ç±Ý ÆÐµå¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¸¦ ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿ä½Ç±Ý ÆÐµå ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

  • Á¦Ç° À¯Çüº°·Î´Â ÀÏȸ¿ë ÆÐµå°¡ 2022³â 93.3%·Î °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÀÏȸ¿ë ¿ä½Ç±Ý ÆÐµå »ç¿ë Áõ°¡¿Í ģȯ°æ Á¦Ç°¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡µµ ÀÌ ºÐ¾ßÀÇ ¼ºÀå¿¡ ±â¿©ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • ȯÀÚº°·Î´Â ÀÓ½Å, Ãâ»ê, Æó°æ µî ¿©·¯ °¡Áö º´¸®·Î ÀÎÇØ ¿©¼º ¿ä½Ç±Ý ¹ß»ý·üÀÌ ³²¼º¿¡ ºñÇØ ³ô±â ¶§¹®¿¡ ¿©¼º¿ë ¿ä½Ç±Ý ÆÐµå ½ÃÀåÀÌ 2022³â 64.6%ÀÇ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • ÃÖÁ¾ ¿ëµµº°·Î´Â 2022³â È£½ºÇÇÅ»¸®Æ¼ ºÎ¹®ÀÌ 32.7%ÀÇ Á¡À¯À²·Î ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½ÅÀå ÁúȯÀÇ Áõ°¡·Î ÀÎÇØ º´¿ø ¹æ¹®ÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀϺΠ½ÅÀå Áúȯ¿¡ ´ëÇÑ ¼ö¼úÀÌ Áõ°¡Çϸ鼭 ÀÌ ºÎ¹®ÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.
  • ÆÇ¸Å ä³Îº°·Î´Â ¿ÀÇÁ¶óÀÎ ÆÇ¸Å ºÎ¹®ÀÌ 2022³â 63.9%·Î °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ºÎ¹®ÀÇ ¼ºÀå ¿äÀÎÀº ¿ä½Ç±Ý ÆÐµåÀÇ ¼Ò¸Å ±¸¸Å Áõ°¡, ¼ÒºñÀÚ°¡ ½±°Ô ±¸ÇÒ ¼ö ÀÖ´Â Á¦Ç°À» ã´Â °æÇâ, Á¢±Ù¼º µîÀÌ ÀÖ½À´Ï´Ù.
  • À¯·´Àº 2022³â 43.5%ÀÇ ¸ÅÃâ Á¡À¯À²·Î ½ÃÀåÀ» Àå¾ÇÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÀÌ´Â ÀÇ·á ÀÎÇÁ¶ó ±¸Ãà, ³ëÀÎ Àα¸ Áõ°¡, À¯·´ ±¹°¡µéÀÇ ¿ä½Ç±Ý À¯º´·ü Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¿ä½Ç±Ý ÆÐµå ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
    • »óºÎ ½ÃÀå Àü¸Á
    • °ü·Ã/ºÎ¼ö ½ÃÀå Àü¸Á
  • º¸±Þ°ú ¼ºÀå Àü¸Á ¸ÅÇÎ
  • ¾÷°èÀÇ ¹ë·ùüÀÎ ºÐ¼®
    • »óȯ ü°è
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • ¿ä½Ç±Ý ÆÐµå ½ÃÀå ºÐ¼® Åø
    • ¾÷°è ºÐ¼® - Porter's
    • PESTEL ºÐ¼®
    • ÁÖ¿ä °Å·¡¿Í Àü·«Àû Á¦ÈÞ ºÐ¼®
    • ½ÃÀå ÁøÃâ Àü·«

Á¦4Àå ¿ä½Ç±Ý ÆÐµå ½ÃÀå : Á¦Ç° À¯Çü ÃßÁ¤¡¤µ¿Ç⠺м®

  • Á¤ÀÇ¿Í ¹üÀ§
  • Á¦Ç° À¯Çü ½ÃÀå Á¡À¯À², 2022³â ¹× 2030³â
  • ºÎ¹® ´ë½Ãº¸µå
  • Á¦Ç° À¯Çüº° ¼¼°èÀÇ ¿ä½Ç±Ý ÆÐµå ½ÃÀå Àü¸Á
  • ´ÙÀ½ÀÇ ½ÃÀå ±Ô¸ð, ¿¹Ãø ¹× µ¿Ç⠺м®, 2018³â¿¡¼­ 2030³â±îÁö
    • Àç»ç¿ë °¡´ÉÇÑ ÆÐµå
    • ÀÏȸ¿ë ÆÐµå

Á¦5Àå ¿ä½Ç±Ý ÆÐµå ½ÃÀå : ȯÀÚ ÃßÁ¤¡¤µ¿Ç⠺м®

  • Á¤ÀÇ¿Í ¹üÀ§
  • ¼½¼Ç ½ÃÀå Á¡À¯À², 2022³â ¹× 2030³â
  • ºÎ¹® ´ë½Ãº¸µå
  • ȯÀÚº° ¿ä½Ç±Ý ÆÐµå ½ÃÀå Àü¸Á
  • ´ÙÀ½ÀÇ ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®, 2018³â¿¡¼­ 2030³â±îÁö
    • ¿©¼º¿ë ¿ä½Ç±Ý ÆÐµå
    • ³²¼º¿ë ¿ä½Ç±Ý ÆÐµå

Á¦6Àå ¿ä½Ç±Ý ÆÐµå ½ÃÀå : ÃÖÁ¾ ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®

  • Á¤ÀÇ¿Í ¹üÀ§
  • ÃÖÁ¾ ¿ëµµ ½ÃÀå Á¡À¯À², 2022³â ¹× 2030³â
  • ºÎ¹® ´ë½Ãº¸µå
  • ÃÖÁ¾ ¿ëµµº° ¿ä½Ç±Ý ÆÐµå ½ÃÀå Àü¸Á
  • ´ÙÀ½ÀÇ ½ÃÀå ±Ô¸ð, ¿¹Ãø ¹× µ¿Ç⠺м®, 2018³â¿¡¼­ 2030³â±îÁö
    • º´¿ø
    • Ŭ¸®´Ð
    • ¿ä¾ç½Ã¼³
    • ȨÄÉ¾î ¼³Á¤
    • ±âŸ

Á¦7Àå ¿ä½Ç±Ý ÆÐµå ½ÃÀå : À¯Åë ä³Î ÃßÁ¤¡¤µ¿Ç⠺м®

  • Á¤ÀÇ¿Í ¹üÀ§
  • À¯Åë ä³Î ½ÃÀå Á¡À¯À², 2022³â ¹× 2030³â
  • ºÎ¹® ´ë½Ãº¸µå
  • ÆÇ¸Å ä³Îº° ¿ä½Ç±Ý ÆÐµå ½ÃÀå Àü¸Á
  • ´ÙÀ½ÀÇ ½ÃÀå ±Ô¸ð, ¿¹Ãø ¹× µ¿Ç⠺м®, 2018³â¿¡¼­ 2030³â±îÁö
    • ¿ÀÇÁ¶óÀÎ ÆÇ¸Å
    • ¿Â¶óÀÎ ÆÇ¸Å

Á¦8Àå ¿ä½Ç±Ý ÆÐµå ½ÃÀå : Áö¿ª ÃßÁ¤¡¤µ¿Ç⠺м®

  • Áö¿ª ½ÃÀå Á¡À¯À² ºÐ¼®, 2022³â ¹× 2030³â
  • Áö¿ª ½ÃÀå ´ë½Ãº¸µå
  • ¼¼°èÀÇ Áö¿ª ½ÃÀå ÇöȲ
  • Áö¿ª ½ÃÀå Á¡À¯À²°ú ÁÖ¿ä ±â¾÷, 2022³â
    • ºÏ¹Ì
    • À¯·´
    • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ½ÃÀå ¾ÖÇø®ÄÉÀ̼Ç, ¿¹Ãø ¹× µ¿Ç⠺м®, 2018³â¿¡¼­ 2030³â :
  • ºÏ¹Ì
    • ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • µ§¸¶Å©
    • ½º¿þµ§
    • ³ë¸£¿þÀÌ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Àεµ
    • Áß±¹
    • Çѱ¹
    • È£ÁÖ
    • ű¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • Äí¿þÀÌÆ®

Á¦9Àå °æÀï »óȲ

  • ÁÖ¿ä ½ÃÀå ÁøÃâ ±â¾÷¿¡ ÀÇÇÑ ÃÖ±ÙÀÇ µ¿Çâ°ú ¿µÇ⠺м®
  • ȸ»ç/°æÀï ºÐ·ù
    • À̳뺣ÀÌÅÍ
  • º¥´õ »óȲ
    • List of key distributors and channel partners
    • Key customers
    • Key company market share analysis, 2022
    • Cardinal Health Inc.
    • Kimberly Clark Corporation
    • Medline Industries, LP.
    • Procter &Gamble
    • ABENA A/S
    • PAUL HARTMANN AG
    • Essity Aktlebolag(publ)
    • Ontex BV
ksm 23.09.06

Incontinence Pads Market Growth & Trends

The global incontinence pads market size is expected to reach USD 10.64 billion by 2030, growing at a CAGR of 5.73% from 2023 to 2030, according to a new report by Grand View Research, Inc. An increase in nephrological complications and kidney disorders, technological advancements in the material used for manufacturing disposable incontinence pads, and growing public awareness of personalized care and hygiene are some key factors responsible for the market growth.

For instance, the American Urology Association reports that up to twenty-five percent of men and women in the U.S. suffer from urine incontinence, while about 33 million people are experiencing hyperactive bladder, which manifests as urgency, frequency, and urge continence. As a result, incontinence pads are being suggested to people by doctors to control this urgency and frequency. Thus, it is expected that during the forecast period, demand for incontinence pads will increase.

Additionally, an increase in numerous renal ailments is expected to aid in the market's growth. For instance, according to data from Kidney Care 2021 in the UK, over 68,000 people are receiving treatment for kidney failure, and over 3.5 million have chronic renal disease. The research also noted that renal failure occurs in about 20 persons in the UK daily.

Additionally, the ABC UK report from October 2022 states that an estimated 20,500 new instances of bladder cancer are diagnosed each year in the UK, accounting for 4.5% of all new cancer cases. As a result, the increased bladder cancer prevalence across the globe is anticipated to be the primary driver fuelling the growing need for incontinence pads for bladder cancer.

Incontinence Pads Market Report Highlights

  • Based on product type, the disposable pads segment accounted for the largest market share of 93.3% in 2022. The increasing use of single-use incontinence pads and growing preference for eco-friendly products are also expected to contribute to segment growth
  • Based on patient, the female incontinence pads segment dominated the market in terms of revenue share of 64.6% in 2022 due to the high incidence rate of incontinence in females when compared with men's owing to several medical conditions such as pregnancy, childbirth, and menopause
  • Based on end-use, the hospital's segment dominated the market with a share of 32.7% in 2022. The increase in renal diseases has led to increased hospital visits, and an increase in surgical procedures for several kidney diseases has been attributed to the segment's growth
  • Based on distribution channel, the offline sales segment held the largest market share of 63.9% in 2022. The factors responsible for segmental growth are increasing retail purchases of incontinence pads, consumers' search for easily accessible goods, and ease of availability
  • Europe dominated the market with a revenue share of 43.5% in 2022, owing to well-established healthcare infrastructure, a growing geriatric population, and the rising prevalence of urinary incontinence in several European countries

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product Type
    • 1.1.2. Patient
    • 1.1.3. End-use
    • 1.1.4. Distribution Channel
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Type outlook
    • 2.2.2. Patient outlook
    • 2.2.3. End-use outlook
    • 2.2.4. Distribution Channel outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Incontinence Pads Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. Growing prevalence of kidney disorders
      • 3.4.1.2. Technological advancements in materials used for disposable incontinence pads
      • 3.4.1.3. Rising geriatric population
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. Lack of awareness about the management of urinary incontinence in developing countries
      • 3.4.2.2. Lack of adoption of incontinence pads in developing countries
  • 3.5. Incontinence Pads Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. The threat of new entrants
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape
    • 3.5.3. Major Deals & Strategic Alliances Analysis
    • 3.5.4. Market Entry Strategies

Chapter 4. Incontinence Pads Market: Product Type Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Reusable Pads
    • 4.1.2. Disposable Pads
  • 4.2. Product Type Market Share, 2022 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Incontinence Pads Market by Product Type Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Reusable Pads
      • 4.5.1.1. Reusable pads market estimates and forecast 2018 to 2030 (USD Billion)
    • 4.5.2. Disposable Pads
      • 4.5.2.1. Disposable pads market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 5. Incontinence Pads Market: Patient Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Female incontinence pads
    • 5.1.2. Male incontinence pads
  • 5.2. Section Market Share, 2022 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Incontinence Pads Market by Patient Outlook
  • 5.5. Market Size & Forecasts and Trend Analysis, 2018 to 2030 for the following
    • 5.5.1. Female incontinence pads
      • 5.5.1.1. Female incontinence pads market estimates and forecast 2018 to 2030 (USD Billion)
    • 5.5.2. Male incontinence pads
      • 5.5.2.1. Male incontinence pads market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 6. Incontinence Pads Market: End-use Estimates & Trend Analysis

  • 6.1. Definitions and Scope
    • 6.1.1. Hospitals
    • 6.1.2. Clinics
    • 6.1.3. Long-term care facilities
    • 6.1.4. Homecare settings
    • 6.1.5. Others
  • 6.2. End-use Market Share, 2022 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Incontinence Pads Market by End-use Outlook
  • 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.5.1. Hospitals
      • 6.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Billion)
    • 6.5.2. Clinics
      • 6.5.2.1. Clinics market estimates and forecast 2018 to 2030 (USD Billion)
    • 6.5.3. Long-term care facilities
      • 6.5.3.1. Long-term care facilities market estimates and forecast 2018 to 2030 (USD Billion)
    • 6.5.4. Homecare settings
      • 6.5.4.1. Homecare settings market estimates and forecast 2018 to 2030 (USD Billion)
    • 6.5.5. Others
      • 6.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 7. Incontinence Pads Market: Distribution Channel Estimates & Trend Analysis

  • 7.1. Definitions and Scope
    • 7.1.1. Offline sales
    • 7.1.2. Online sales
  • 7.2. Distribution Channel Market Share, 2022 & 2030
  • 7.3. Segment Dashboard
  • 7.4. Incontinence Pads Market by Distribution Channel Outlook
  • 7.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.5.1. Offline sales
      • 7.5.1.1. Offline sales market estimates and forecast 2018 to 2030 (USD Billion)
      • 7.5.1.2. Hospital pharmacies
      • 7.5.1.2.1. Hospital pharmacies market estimates and forecast 2018 to 2030 (USD Billion)
      • 7.5.1.3. Retail pharmacies
      • 7.5.1.3.1. Retail pharmacies market estimates and forecast 2018 to 2030 (USD Billion)
      • 7.5.1.4. Hypermarkets and Supermarkets
      • 7.5.1.4.1. Hypermarkets and supermarkets market estimates and forecast 2018 to 2030 (USD Billion)
    • 7.5.2. Online Sales
      • 7.5.2.1. Online sales market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 8. Incontinence Pads Market: Regional Estimates & Trend Analysis

  • 8.1. Regional market share analysis, 2022 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. Regional Market Share and Leading Players, 2022
    • 8.4.1. North America
    • 8.4.2. Europe
    • 8.4.3. Asia Pacific
    • 8.4.4. Latin America
    • 8.4.5. Middle East and Africa
  • 8.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030:
  • 8.6. North America
    • 8.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 8.6.2. The U.S.
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory framework
      • 8.6.2.4. U.S. market estimates and forecasts, 2018 - 2030
    • 8.6.3. Canada
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory framework
      • 8.6.3.4. Canada market estimates and forecasts, 2018 - 2030
  • 8.7. Europe
    • 8.7.1. UK
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Competitive Scenario
      • 8.7.1.3. Regulatory framework
      • 8.7.1.4. UK market estimates and forecasts, 2018 - 2030
    • 8.7.2. Germany
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory framework
      • 8.7.2.4. Germany market estimates and forecasts, 2018 - 2030
    • 8.7.3. France
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory framework
      • 8.7.3.4. France market estimates and forecasts, 2018 - 2030
    • 8.7.4. Italy
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory framework
      • 8.7.4.4. Italy market estimates and forecasts, 2018 - 2030
    • 8.7.5. Spain
      • 8.7.5.1. Key country dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory framework
      • 8.7.5.4. Spain market estimates and forecasts, 2018 - 2030
    • 8.7.6. Denmark
      • 8.7.6.1. Key country dynamics
      • 8.7.6.2. Competitive Scenario
      • 8.7.6.3. Regulatory framework
      • 8.7.6.4. Denmark market estimates and forecasts, 2018 - 2030
    • 8.7.7. Sweden
      • 8.7.7.1. Key country dynamics
      • 8.7.7.2. Competitive Scenario
      • 8.7.7.3. Regulatory framework
      • 8.7.7.4. Sweden market estimates and forecasts, 2018 - 2030
    • 8.7.8. Norway
      • 8.7.8.1. Key country dynamics
      • 8.7.8.2. Competitive Scenario
      • 8.7.8.3. Regulatory framework
      • 8.7.8.4. Norway market estimates and forecasts, 2018 - 2030
  • 8.8. Asia Pacific
    • 8.8.1. Japan
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Competitive Scenario
      • 8.8.1.3. Regulatory framework
      • 8.8.1.4. Japan market estimates and forecasts, 2018 - 2030
    • 8.8.2. India
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Competitive Scenario
      • 8.8.2.3. Regulatory framework
      • 8.8.2.4. India market estimates and forecasts, 2018 - 2030
    • 8.8.3. China
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Competitive Scenario
      • 8.8.3.3. Regulatory framework
      • 8.8.3.4. China market estimates and forecasts, 2018 - 2030
    • 8.8.4. South Korea
      • 8.8.4.1. Key country dynamics
      • 8.8.4.2. Competitive Scenario
      • 8.8.4.3. Regulatory framework
      • 8.8.4.4. South Korea market estimates and forecasts, 2018 - 2030
    • 8.8.5. Australia
      • 8.8.5.1. Key country dynamics
      • 8.8.5.2. Competitive Scenario
      • 8.8.5.3. Regulatory framework
      • 8.8.5.4. Australia market estimates and forecasts, 2018 - 2030
    • 8.8.6. Thailand
      • 8.8.6.1. Key country dynamics
      • 8.8.6.2. Competitive Scenario
      • 8.8.6.3. Regulatory framework
      • 8.8.6.4. Thailand market estimates and forecasts, 2018 - 2030
  • 8.9. Latin America
    • 8.9.1. Brazil
      • 8.9.1.1. Key country dynamics
      • 8.9.1.2. Competitive Scenario
      • 8.9.1.3. Regulatory framework
      • 8.9.1.4. Brazil market estimates and forecasts, 2018 - 2030
    • 8.9.2. Mexico
      • 8.9.2.1. Key country dynamics
      • 8.9.2.2. Competitive Scenario
      • 8.9.2.3. Regulatory framework
      • 8.9.2.4. Mexico market estimates and forecasts, 2018 - 2030
    • 8.9.3. Argentina
      • 8.9.3.1. Key country dynamics
      • 8.9.3.2. Competitive Scenario
      • 8.9.3.3. Regulatory framework
      • 8.9.3.4. Argentina market estimates and forecasts, 2018 - 2030
  • 8.10. MEA
    • 8.10.1. South Africa
      • 8.10.1.1. Key country dynamics
      • 8.10.1.2. Competitive Scenario
      • 8.10.1.3. Regulatory framework
      • 8.10.1.4. South Africa market estimates and forecasts, 2018 - 2030
    • 8.10.2. Saudi Arabia
      • 8.10.2.1. Key country dynamics
      • 8.10.2.2. Competitive Scenario
      • 8.10.2.3. Regulatory framework
      • 8.10.2.4. Saudi Arabia market estimates and forecasts, 2018 - 2030
    • 8.10.3. UAE
      • 8.10.3.1. Key country dynamics
      • 8.10.3.2. Competitive Scenario
      • 8.10.3.3. Regulatory framework
      • 8.10.3.4. UAE market estimates and forecasts, 2018 - 2030
    • 8.10.4. Kuwait
      • 8.10.4.1. Key country dynamics
      • 8.10.4.2. Competitive Scenario
      • 8.10.4.3. Regulatory framework
      • 8.10.4.4. Kuwait market estimates and forecasts, 2018 - 2030

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
    • 9.2.1. Innovators
  • 9.3. Vendor Landscape
    • 9.3.1. List of key distributors and channel partners
    • 9.3.2. Key customers
    • 9.3.3. Key company market share analysis, 2022
    • 9.3.4. Cardinal Health Inc.
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. Kimberly Clark Corporation
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Medline Industries, LP.
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. Procter & Gamble
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. ABENA A/S
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. PAUL HARTMANN AG
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Product benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. Essity Aktlebolag (publ)
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Product benchmarking
      • 9.3.10.4. Strategic initiatives
    • 9.3.11. Ontex BV
      • 9.3.11.1. Company overview
      • 9.3.11.2. Financial performance
      • 9.3.11.3. Product benchmarking
      • 9.3.11.4. Strategic initiatives
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦